Where Plasma p-tau217 is reported
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Alzheimer's Disease and Other Dementias | ↑ elevated | PSEN1 E280A mutation non-carriers | not specified | Malotaux et al. 2025 |
Frequently asked questions
In which conditions is Plasma p-tau217 altered?
In the OSMF atlas Plasma p-tau217 is reported in Alzheimer's Disease and Other Dementias. It is elevated in 1 across 1 entries.
Is there a standard clinical test for Plasma p-tau217?
The atlas entries for Plasma p-tau217 do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal Plasma p-tau217 result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.